Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
0.00%
)
US TECH 100
26,161.20
(
-0.16%
)
Dow Jones
49,490.03
(
0.00%
)
Brent Oil
98.17
(
1.49%
)
Bitcoin
77,831.70
(
-0.52%
)
News Focus
News Focus

Replies to post #4773 on Revance Therapeutics Inc (RVNC)

Replies to #4773 on Revance Therapeutics Inc (RVNC)
icon url

DewDiligence

10/12/23 3:29 PM

#4775 RE: mouton29 #4773

Okay—thanks. Still, the 80% "PoS" figure was ludicrous in its own right, given that the Daxxify sBLA for CD had no new formulation or manufacturing requirements and Daxxify's clinical dataset in CD was superb.